Search for: "SELLERS v. WYETH"
Results 21 - 40
of 67
Sorted by Relevance
|
Sort by Date
5 Jan 2011, 4:42 am
White v. [read post]
6 Sep 2013, 8:10 am
Wyeth, No. 12-6078, 2013 U.S. [read post]
17 Sep 2015, 3:01 pm
Wyeth, Inc., 85 Cal. [read post]
9 Mar 2012, 2:20 pm
(See, for instance, his concurrence in Wyeth v. [read post]
15 Sep 2011, 4:06 am
Wyeth. [read post]
26 Mar 2013, 9:35 am
Wyeth, 15 A.3d 429 (Pa. 2011)(Court granted allocatur to address appeal in products liability case; this appeal may represent another opportunity for the Pennsylvania Supreme Court to revisit the Restatement (Second) versus (Third) debate and finally clarify the issue).U.S. [read post]
10 Jul 2015, 4:30 am
Jan. 11, 2013) (withdrawn and superseded), and Wyeth, Inc. v. [read post]
11 Nov 2010, 12:54 pm
Wyeth, Inc., 2006 WL 2883030, at *4 (W.D. [read post]
10 Nov 2011, 12:50 pm
Wyeth Pharmaceuticals, 471 F. [read post]
29 Jun 2011, 5:00 am
For the reasons why other courts disagree, we recommend reading Alm v. [read post]
3 Dec 2013, 7:54 am
See Strayhorn v. [read post]
28 Oct 2015, 4:30 am
Garcia v. [read post]
8 Nov 2013, 5:00 am
Wyeth, 158 Cal. [read post]
25 Mar 2012, 7:16 pm
Wyeth v. [read post]
24 Aug 2015, 5:00 am
Wyeth Pharmaceuticals, 797 F. [read post]
2 Jul 2015, 11:18 am
(citing Foster v. [read post]
21 Nov 2012, 5:00 am
Wyeth-Ayerst Labs., 385 F.3d 961, 966 (6th Cir. 2004) (holding that a drug manufacturer is immune from suit unless “the FDA itself determines that a fraud has been committed on the agency during the regulatory-approval process”) citing Buckman Co. v. [read post]
24 Feb 2012, 6:37 am
., LLC v. [read post]
29 Mar 2013, 2:00 pm
Section 402A also expanded the scope of possible liable parties to also include all sellers in the distribution process related to the dissemination of the product to the public at large. [read post]
25 Jun 2015, 5:00 am
Wyeth, 705 S.E.2d 828 (W. [read post]
